MIT Libraries homeMIT Libraries logoDSpace@MIT

MIT
View Item 
  • DSpace@MIT Home
  • MIT Open Access Articles
  • MIT Open Access Articles
  • View Item
  • DSpace@MIT Home
  • MIT Open Access Articles
  • MIT Open Access Articles
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

A validated single-cell-based strategy to identify diagnostic and therapeutic targets in complex diseases

Author(s)
Gawel, Danuta R.; Serra-Musach, Jordi; Lilja, Sandra; Aagesen, Jesper; Arenas, Alex; Asking, Bengt; Bengnér, Malin; Björkander, Janne; Biggs, Sophie; Ernerudh, Jan; Hjortswang, Henrik; Karlsson, Jan-Erik; Köpsen, Mattias; Lee, Eun Jung; Lentini, Antonio; Li, Xinxiu; Magnusson, Mattias; Martínez-Enguita, David; Matussek, Andreas; Nestor, Colm E.; Schäfer, Samuel; Seifert, Oliver; Sonmez, Ceylan; Stjernman, Henrik; Tjärnberg, Andreas; Wu, Simon; Åkesson, Karin; Shalek, Alexander K; Stenmarker, Margaretha; Zhang, Huan; Gustafsson, Mika; Benson, Mikael; ... Show more Show less
Thumbnail
DownloadPublished version (7.875Mb)
Terms of use
Creative Commons Attribution 4.0 International license https://creativecommons.org/licenses/by/4.0/
Metadata
Show full item record
Abstract
Background: Genomic medicine has paved the way for identifying biomarkers and therapeutically actionable targets for complex diseases, but is complicated by the involvement of thousands of variably expressed genes across multiple cell types. Single-cell RNA-sequencing study (scRNA-seq) allows the characterization of such complex changes in whole organs. Methods: The study is based on applying network tools to organize and analyze scRNA-seq data from a mouse model of arthritis and human rheumatoid arthritis, in order to find diagnostic biomarkers and therapeutic targets. Diagnostic validation studies were performed using expression profiling data and potential protein biomarkers from prospective clinical studies of 13 diseases. A candidate drug was examined by a treatment study of a mouse model of arthritis, using phenotypic, immunohistochemical, and cellular analyses as read-outs. Results: We performed the first systematic analysis of pathways, potential biomarkers, and drug targets in scRNA-seq data from a complex disease, starting with inflamed joints and lymph nodes from a mouse model of arthritis. We found the involvement of hundreds of pathways, biomarkers, and drug targets that differed greatly between cell types. Analyses of scRNA-seq and GWAS data from human rheumatoid arthritis (RA) supported a similar dispersion of pathogenic mechanisms in different cell types. Thus, systems-level approaches to prioritize biomarkers and drugs are needed. Here, we present a prioritization strategy that is based on constructing network models of disease-associated cell types and interactions using scRNA-seq data from our mouse model of arthritis, as well as human RA, which we term multicellular disease models (MCDMs). We find that the network centrality of MCDM cell types correlates with the enrichment of genes harboring genetic variants associated with RA and thus could potentially be used to prioritize cell types and genes for diagnostics and therapeutics. We validated this hypothesis in a large-scale study of patients with 13 different autoimmune, allergic, infectious, malignant, endocrine, metabolic, and cardiovascular diseases, as well as a therapeutic study of the mouse arthritis model. Conclusions: Overall, our results support that our strategy has the potential to help prioritize diagnostic and therapeutic targets in human disease. Keywords: Network tools; scRNA-seq; Biomarker and drug discovery
Date issued
2019-07-30
URI
https://hdl.handle.net/1721.1/123667
Department
Massachusetts Institute of Technology. Institute for Medical Engineering and Science; Massachusetts Institute of Technology. Department of Chemistry; David H. Koch Institute for Integrative Cancer Research at MIT; Broad Institute of MIT and Harvard; Broad Institute of MIT and Harvard
Journal
Genome Medicine
Publisher
Springer Science+Business Media
Citation
Gawel, Danuta R. et al. "A validated single-cell-based strategy to identify diagnostic and therapeutic targets in complex diseases." Genome Medicine, 11, (July 2019): 47 © 2019 The Authors
Version: Final published version
ISSN
1756-994X
Keywords
Genetics(clinical), Molecular Medicine, Genetics, Molecular Biology

Collections
  • MIT Open Access Articles

Browse

All of DSpaceCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects

My Account

Login

Statistics

OA StatisticsStatistics by CountryStatistics by Department
MIT Libraries homeMIT Libraries logo

Find us on

Twitter Facebook Instagram YouTube RSS

MIT Libraries navigation

SearchHours & locationsBorrow & requestResearch supportAbout us
PrivacyPermissionsAccessibility
MIT
Massachusetts Institute of Technology
Content created by the MIT Libraries, CC BY-NC unless otherwise noted. Notify us about copyright concerns.